<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Serotonin Pharmacology &amp; Migraine</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Serotonin Pharmacology &amp; Migraine</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                13 Questions | 13 Total Marks | 23 min Duration | ~106.15 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 13 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 23 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 13</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Serotonin Pharmacology &amp; Migraine - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 13</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 13 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Among the following options, Pitolisant is used in treatment in which condition?", "options": [{"label": "A", "text": "Epilepsy", "correct": false}, {"label": "B", "text": "Cataplexy", "correct": false}, {"label": "C", "text": "Narcolepsy", "correct": true}, {"label": "D", "text": "Anorexia nervosa", "correct": false}], "correct_answer": "C. Narcolepsy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Narcolepsy Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms often include periods of excessive daytime sleepiness and brief involuntary sleep episodes. About 70% of those affected also experience episodes of sudden loss of muscle strength, known as cataplexy.</p>\n<p><strong>Highyeild:</strong></p><p>Pitolisant also called as tiprolisant ORPHAN drug It is a potent, orally active histamine H3 receptor antagonist/inverse agonist acts by blockade of histamine auto-receptors and enhances the activity of brain histaminergic neurons, a major arousal system with widespread projections to the whole brain used to treat narcolepsy with or without cataplexy</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Epilepsy is a group of non-communicable neurological disorders characterized by recurrent epileptic seizures. An epileptic seizure is the clinical manifestation of an abnormal, excessive, purposeless and synchronized electrical discharge in the brain cells called neurons. Option: B. Cataplex y is a sudden muscle weakness that occurs while a person is awake. Strong emotions trigger cataplexy. The triggering experiences are usually positive, like laughter, witty conversations, and pleasant surprise. Episodes may also be triggered by anger, but rarely by stress, fear, or physical exertion. Option: D. Anorexia nervosa is an eating disorder characterized by low weight, food restriction, body image disturbance, fear of gaining weight, and an overpowering desire to be thin. Anorexia is a term of Greek origin: an- (·ºÄŒΩ-, prefix denoting negation) and orexis ( \"appetite\"), translating literally to \"a loss of appetite\".</p>\n<p><strong>Table:</strong></p><p>Medications\n  used to treat narcolepsy EDS and their most common side effects in clinical\n  practice Drug Most\n  common side effects References Modafinil Headache,\n  nausea, insomnia, anxiety, especially in the first days of treatment [10-13,\n  15] Methylphenidate Tachycardia,\n  hypertension, palpitations, neuropsychiatric symptoms (anxiety,\n  irritability), weight loss [16] Sodium\n  oxybate Dizziness,\n  headache, nausea, weight loss, restless leg syndrome, parasomnias\n  (sleepwalking, enuresis), neuropsychiatric symptoms (confusion, anxiety,\n  depressive symptoms) [17-19] Pitolisant a Headache,\n  nausea, insomnia [20,\n  21] Amphetamines b Cardiac\n  arrhythmias, hypertension, neuropsychiatric symptoms (irritability,\n  aggressiveness, psychotic symptoms), insomnia, abnormal movements [22,\n  23] Mazindol a Dry\n  mouth, nervousness, constipation, rare reports of pulmonary hypertension and\n  valvular heart disease [24,\n  25]</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Among the following options, which one is the Drug having Anti PAF activity?", "options": [{"label": "A", "text": "Loxatidine", "correct": false}, {"label": "B", "text": "Nizatidine", "correct": false}, {"label": "C", "text": "Rupatidine", "correct": true}, {"label": "D", "text": "loratadine", "correct": false}], "correct_answer": "C. Rupatidine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Rupatidine Rupatadine fumarate has been approved for the treatment of allergic rhinitis and chronic urticaria in adults and children over 12 years. It is available as round, light salmon-coloured tablets containing 10 mg of rupatadine (as fumarate) to be administered orally, once a day .</p>\n<p><strong>Highyeild:</strong></p><p>Rupatadine antihistaminic has additional PAF antagonistic property used in allergic rhinitis</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Loxatidine and nizatidine are H2 blockers used in acid peptic disease Option: B. Nizatidin e is an antacid. It reduces the amount of acid your stomach makes. It is used to treat and prevent heartburn, indigestion and other symptoms caused by too much acid in the stomach. It is also used to treat and prevent stomach ulcers, reflux disease, and some rarer conditions. Option: D. Loratadine is fast acting and long-acting selective peripheral H1 antagonist</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Among the following options, which one is a 5HT1A agonist used in anxiety?", "options": [{"label": "A", "text": "Bupropion", "correct": false}, {"label": "B", "text": "Buspirone", "correct": true}, {"label": "C", "text": "Budesonide", "correct": false}, {"label": "D", "text": "Buprenorphine", "correct": false}], "correct_answer": "B. Buspirone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Buspirone Buspirone decreases some of the activity of a chemical called serotonin in the brain. This decrease is thought to affect anxiety. Buspirone oral tablet causes drowsiness.</p>\n<p><strong>Highyeild:</strong></p><p>BUSPIRONE Most selective anxiolytic currently available. The anxiolytic effect of this drug takes several weeks to develop => used for GAD. Buspirone does not have sedative effects and does not potentiate CNS depressants. Has a relatively high margin of safety, few side effects and does not appear to be associated with drug dependence. No rebound anxiety or signs of withdrawal when discontinued. Buspirone acts on serotonin receptor is a 5HT 1A partial agonist used in anxiety no sedation and abuse table,tr,th,td {border:1px solid black;} BUSPIRONE Side effects: ‚óè       Tachycardia, palpitations, nervousness, Gl distress and paresthesias may occur. ‚óè       Causes a dose-dependent pupillary constriction.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Bupropion is an atypical antidepressant used to treat major depressive disorder and is also used for smoking cessation. Option: C. Budesonide is an inhalational corticosteroid Option: D. Buprenorphine is a highly lipid-soluble opioid analgesic used to treat dependence on opioids. BUSPIRONE Side effects: ‚óè       Tachycardia, palpitations, nervousness, Gl distress and paresthesias may occur. ‚óè       Causes a dose-dependent pupillary constriction.</p>\n<p><strong>Table:</strong></p><p>Buspirone\n(Buspar) Mechanism\n     of Action Non-benzodiazepine\n      anxiolytic 5HT-1A\n      partial agonist No action\n      on GABA Antianxiolytic\n     effect takes longer to achieve 2-3 weeks Side\n     Effects GI upset,\n      headache, nervousness Less\n     sedating than benzos, no psychomotor or cognitive impairment, no\n     withdrawal symptoms, little abuse potential</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Among the following triptans, longest acting triptan is:", "options": [{"label": "A", "text": "Frovatriptan", "correct": true}, {"label": "B", "text": "Rizatriptan", "correct": false}, {"label": "C", "text": "Sumatriptan", "correct": false}, {"label": "D", "text": "Naratriptan", "correct": false}], "correct_answer": "A. Frovatriptan", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Frovatriptan rizatriptan is the fastest acting and frovatriptan is the longest-acting in the group Selective 5-HT1D/1B agonists (Triptans) This novel class of antimigraine drugs selectively activate 5-HT1D/1B receptors, and are called ‚Äòtriptans‚Äô. Currently, they are the first-line drugs for patients who fail to respond to analgesics. Ergot alkaloids are now required only in a few cases. Because these drugs have been designed to act on the same subtype of the 5-HT receptor, pharmacodynamic differences among them are minor, but there are significant pharmacokinetic differences.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B .Rizatriptan: is a medication used for the treatment of migraine headaches. It is taken by mouth. Common side effects include chest pain, dizziness, dry mouth, and tingling. Other side effects may include myocardial infarction, stroke, high blood pressure, serotonin Option: C. Sumatriptan belongs to a class of drugs called serotonin-1 receptor agonists. A class of drugs is a group of medications that work in a similar way. These drugs are often used to treat similar conditions. A migraine causes the blood vessels in the brain to expand. Option: D. Naratriptan: It relieves the symptoms of migraine and prevents the attack from becoming worse. This medicine helps by narrowing the blood vessels, thereby relieving the migraine headaches.</p>\n<p><strong>Extraedge:</strong></p><p>All other triptans have higher oral bioavailability than the prototype drug sumatriptan. Fewer headache recurrences in an attack are reported with naratriptan and frovatriptan due to their longer t¬Ω, but they may be slower in affording initial pain relief.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following drug is used in prophylaxis of migraine?", "options": [{"label": "A", "text": "Fludarabine", "correct": false}, {"label": "B", "text": "Fludrocortisone", "correct": false}, {"label": "C", "text": "Flumazenil", "correct": false}, {"label": "D", "text": "Flunarizine", "correct": true}], "correct_answer": "D. Flunarizine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Flunarizine Flunarizine, Mechanism of action Flunarizine is a selective calcium antagonist with moderate other actions including antihistamine, serotonin receptor blocking and dopamine D2 blocking activity. Compared to other calcium channel blockers such as dihydropyridine derivatives, verapamil and diltiazem, flunarizine</p>\n<p><strong>Highyeild:</strong></p><p>Flunarizine is a cerebro-selective T-type Ca2+ channel blocker used in the prophylaxis of migraine Flunarizine is a relatively weak Ca2+ channel blocker that inhibits Na+ channels as well. It is claimed to be as effective as propranolol. The frequency of attacks is often reduced, but the effect on intensity and duration of attacks is less well documented. It is claimed to be a cerebro-selective Ca2+ channel blocker, which may benefit migraine by reducing intracellular Ca2+ overload due to brain hypoxia and other causes. Side effects are sedation, constipation, dry mouth, hypotension, flushing, weight gain and rarely extrapyramidal symptoms.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Fludarabine is a purine analogue and antineoplastic agent used for the treatment of leukaemia . Option: B. Fludrocortisone is a corticosteroid used to treat adrenal insufficiency. Option: C. Flumazenil is selective gaba a receptor antagonist ( benzodiazepines antagonis t)</p>\n<p><strong>Table:</strong></p><p>calcium channel\nblocker 1. Dihydropyridines ¬∑ Norm frequent (with normal heart rate) and 24-hours long effect:\nAmlodipine, Felodipine ¬∑ Other dihydropyridines produce tachycardia (increase baroreflex\nsensibility): Isradipine,\nLacidipine, Nicardipine, Nifedipine, Nisoldipine,\nNitrendipine cerebral vasodilators\n     (Nimodipine) 2. Phenylalkylamines: Verapamil 3. Benzotiazepines: Diltiazem 4. Flunarizine type (cerebral vasodilators) Cinnarizine, Flunarizine</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Among the following options, which drug is used for migraine prophylaxis?", "options": [{"label": "A", "text": "Erenumab", "correct": true}, {"label": "B", "text": "Olcegepant", "correct": false}, {"label": "C", "text": "Sumatriptan", "correct": false}, {"label": "D", "text": "Ergotamine", "correct": false}], "correct_answer": "A. Erenumab", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Erenumab Erenumab is a Mab against calcitonin gene-related peptide used for the preventive treatment of migraine in adults.</p>\n<p><strong>Highyeild:</strong></p><p>Erenumab is the first FDA-approved CGRP inhibitor for the prevention of migraine in adults. ARISE study found fewer migraine days/month, and fewer days/month requiring migraine-specific medication for erenumab vs placebo. Statistical modeling study estimated 144 fewer migraine days/patient and >$8000 saved/patient over 10 yrs. Erenumab showed good safety and tolerability, which may encourage adherence in this population with high unmet needs.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. calcitonin gene-related peptide antagonists are Olcegepant and Telcagepant and are used for acute attacks of migraine Options: C, D. Sumatriptan and ergotamine are used for acute attacks</p>\n<p><strong>Extraedge:</strong></p><p>CGRP antagonist A fully human monoclonal antibody Erenumab which blocks calcitonin gene-related peptide (CGRP) receptor has been recently found to reduce the number of migraine attacks when injected s.c. once a month in patients with severe migraine</p>\n<p><strong>Table:</strong></p><p>Proposed\nRole of Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in Migraine CGRP is a\n     potent neuropeptide expressed in the trigeminal system Increased\n     during migraine and cluster headache CGRP\n     receptor antagonists: May act\n      at multiple sites to block the actions of CGRP Are not\n      vasoconstrictors</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 36-year male has been found to have pulmonary fibrosis in the chest x-ray when he did his regular health check-up. His medication history shows that he is under migraine prophylaxis. Which medication would be responsible for his chest X-ray finding?", "options": [{"label": "A", "text": "Sumatriptan", "correct": false}, {"label": "B", "text": "Ergotamine", "correct": false}, {"label": "C", "text": "Methysergide", "correct": true}, {"label": "D", "text": "LSD", "correct": false}], "correct_answer": "C. Methysergide", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Methysergide Methysergide: is used for the prophylactic treatment of migraine and other vascular headaches. A serious complication of prolonged treatment is inflammatory fibrosis.</p>\n<p><strong>Highyeild:</strong></p><p>Methysergide - Serotonin agonist, vasoconstrictor. Highly effective for primary treatment but has side effects on prolonged use (Retroperitoneal fibrosis, Pulmonary fibrosis) - Dose: 2 to 6 mg/day</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Sumatriptan being a triptan, is effective in the treatment of an acute attack of migraine and not for prophylaxis. Only minor side effects are seen with the triptans. Option: B. Ergotamine is an ergot alkaloid. Its use is restricted to patients having frequent, moderate migraine or infrequent, severe migraine attacks. The most common adverse effect seen is Gangrene due to vasoconstriction. Option: D. LSD, a potent hallucinogen acts as a 5HT receptor agonist/partial agonist and elicits sensory distortions (especially visual) and hallucinations. Hence, it is not used therapeutically.</p>\n<p><strong>Table:</strong></p><p>Classification\nof ergot alkaloids Natural - Derivatives\n     of the tetra-cyclic compounds (lysergic acid) Amine alkaloids - Ergometrine (ergonovine) - oxytotic Amino acid alkaloids - Ergotamine, Ergotoxine ... Vasoconstrictor &\na blocker Semi-synthetic -\n     Bromocriptine, Methysergide, Dihydro-ergotamine (DHE) Synthetic - (non\n     lysergic acid derivative) Metergotine</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient has been prescribed Erenumab for migraine prophylaxis. According to which of the following mechanisms will it act?", "options": [{"label": "A", "text": "Blockade of beta-adrenergic receptor", "correct": false}, {"label": "B", "text": "CGRP receptor antagonism", "correct": true}, {"label": "C", "text": "5HT1F agonism", "correct": false}, {"label": "D", "text": "5HT1D/1B agonism", "correct": false}], "correct_answer": "B. CGRP receptor antagonism", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>CGRP receptor antagonism Erenumab is a recently approved monoclonal antibody that acts by CGRP receptor antagonism and reduces the number of migraine attacks.</p>\n<p><strong>Highyeild:</strong></p><p>Proposed Role of Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in Migraine CGRP is a potent neuropeptide expressed in the trigeminal system Increased during migraine and cluster headache CGRP receptor antagonists: - May act at multiple sites to block the actions of CGRP - Are not vasoconstrictors</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Blockade of beta-adrenergic receptor: Propranolol acts by this mechanism and is most commonly used to reduce the frequency as well as the severity of migraine attacks. Option: C. Lasmiditan acts by 5HT1F agonism and it is used in the treatment of an acute attack of migraine. Option: D. Drugs acting by 5HT1D/1B agonism are Triptans. They are the first-line drugs for an acute attack of migraine.</p>\n<p><strong>Table:</strong></p><p>Erenumab\n     is the first FDA-approved CGRP inhibitor for the prevention of migraine in\n     adults. ARISE\n     study found fewer migraine days/month, and fewer days/month requiring\n     migraine-specific medication for erenumab vs placebo. Statistical\n     modeling study estimated 144 fewer migraine days/patient and >$8000\n     saved/patient over 10 yrs. Erenumab\n     showed good safety and tolerability, which may encourage adherence in this\n     population with high unmet needs.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 31-year-old female came with complaints of decreased libido and sexual fear. Which of the following drugs can be prescribed to her?", "options": [{"label": "A", "text": "Lasmiditan", "correct": false}, {"label": "B", "text": "Lorcaserin", "correct": false}, {"label": "C", "text": "Prucalopride", "correct": false}, {"label": "D", "text": "Flibanserin", "correct": true}], "correct_answer": "D. Flibanserin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Flibanserin Flibanserin is a 5HT1A agonist and 5HT2 antagonist. It is recently approved to treat hypoactive sexual desire disorder ( HSDD ) in premenopausal women. It enhances sexual function by decreasing 5HT levels in the cortex.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Lasmidita n is a 5HT1F agonist and it is used in the treatment of an acute attack of migraine. Option: B. Lorcaserin is a 5HT2C agonist approved for weight loss. It decreases food consumption and promotes satiety. Option: C. Prucalopride is a selective 5-HT4 agonist used for the treatment of constipation-predominant IBS.</p>\n<p><strong>Table:</strong></p><p>Indication Hypoactive\n  sexual desire disorder in premenopausal women Dosage 100\n  mg PO QHS Contraindication Hepatic\n  impairment, alcohol and CYP3A4 inhibitors Warning Syncope,\n  hypotension and CNS depression Side\n  Effects Dizziness,\n  somnolence, nausea, fatigue, insomnia, dry mouth Interactions Oral\n  contraceptives, digoxin, CYP3A4 inducers, CYP2C19 inhibitors MOA Serotonin\n  Receptor agonist (5-HT1A) and (5-HT2A) antagonist</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A mother of a 6-year-old boy came to the pediatric department and complained about her son that he is a poor eater and there has been no increase in weight for the past few months. The paediatrician prescribed the boy Cyproheptadine syrup. This drug is known to act on the following receptors except:", "options": [{"label": "A", "text": "Beta-adrenergic receptors", "correct": true}, {"label": "B", "text": "Serotonin receptors", "correct": false}, {"label": "C", "text": "Histaminic receptors", "correct": false}, {"label": "D", "text": "Muscarinic receptors", "correct": false}], "correct_answer": "A. Beta-adrenergic receptors", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Beta-adrenergic receptors Beta-adrenergic receptors: The adrenergic receptors or adrenoceptors are a class of G protein-coupled receptors that are targets of many catecholamines like norepinephrine (noradrenaline) and epinephrine (adrenaline) produced by the body, but also many medications like beta blockers, beta-2 (Œ≤ 2 ) agonists and alpha-2 (Œ± 2 ) agonists, which are used to treat high blood pressure and asthma. Option: A. Cyproheptadine has no additional action on beta-adrenergic</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Options: B, C, D. Cyproheptadine primarily blocks 5-HT2A receptors and has additional H1 antihistaminic, antimuscarinic and sedative properties. So, it has no role in beta-adrenergic receptors. Antihistaminic activity : It is used for allergies and is a good antipruritic. It increases appetite in children as well as in poor eaters and promotes weight gain . Anti-5-HT activity: It controls the intestinal manifestations of carcinoid and post-gastrectomy dumping syndromes . Also used in priapism/ orgasmic delay caused by 5-HT uptake inhibitors like fluoxetine and trazodone. .</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 29-year-old male came has been treated for an acute attack of migraine in the general medicine department. After that, he has prescribed an autoinjector with a drug that he should inject himself when a similar acute attack occurs in the future. Which drug will be present in the autoinjector?", "options": [{"label": "A", "text": "Sumatriptan", "correct": true}, {"label": "B", "text": "Zolmitriptan", "correct": false}, {"label": "C", "text": "Naratriptan", "correct": false}, {"label": "D", "text": "Rizatriptan", "correct": false}], "correct_answer": "A. Sumatriptan", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Sumatriptan Sumatriptan: is a medication used to treat migraine headaches and cluster headaches. It is taken orally, intranasally, or by subcutaneous injection. Therapeutic effects generally occur within three hours.</p>\n<p><strong>Highyeild:</strong></p><p>Sumatriptan has a low oral bioavailability of about 15%. So, it should be given subcutaneously when an acute attack of migraine occurs. After SC injection, it reaches peak plasma concentration in about 12 min. An autoinjector with 6 mg of sumatriptan is available on the market which can be taken by the patients at the home itself if they get an acute attack of migraine.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B . Zolmitriptan is available as a nasal spray and oral formulation. Option: C. Naratriptan & D. Rizatriptan are available in oral formulations. Options: B, C, D. Not preferred in pregnancy as sufficient study of evidence of safety not conducted.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 26-year-old female is diagnosed with postpartum haemorrhage in the labour ward. Which of the ergot alkaloids should be prescribed to her?", "options": [{"label": "A", "text": "Ergometrine", "correct": true}, {"label": "B", "text": "Ergotamine", "correct": false}, {"label": "C", "text": "Dihydroergotoxine", "correct": false}, {"label": "D", "text": "Methysergide", "correct": false}], "correct_answer": "A. Ergometrine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Ergometrine Ergometrine The primary indication for ergometrine/ methylergometrine is to control and prevent postpartum haemorrhage (PPH): 0.2‚Äì0.3 mg i.m. at delivery of anterior shoulder reduces blood loss attending delivery and prevents PPH.</p>\n<p><strong>Highyeild:</strong></p><p>Ergot derivatives Ergometrine & Methyl ergometrine(Methergine) Ergometrine, an alkaloid, isolated by Dudley and Moir,(1935) from Ergot, derived from a fungus, Claviseps purpurea, growing on rye,wheat etc. Methergine is semi synthetic, derived from lysergic acid. Onset of ergometrine is quicker (45-60 secs) than methergine (90 secs) Duration is similar (3hrs).</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. Ergotamin e is used in the treatment of acute attacks of migraine. Option: C . Dihydroergotoxin e has been advocated for the treatment of dementia. Option: D. Methysergide is used for the prophylactic treatment of migraine and other vascular headaches.</p>\n<p><strong>Table:</strong></p><p>ERGOT\nDERIVATIVES Mode of\n     action: Ergometrine\nacts directly on the myometrium Effectiveness It\nis highly effective in hemostasis Indications: Therapeutic: To\nstop the atonic uterine bleeding following delivery, abortion or expulsion of\nhydatidiform mole. Prophylactic: Against\nexcessive haemorrhage following delivery.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A pregnant woman came with complaints from which you have diagnosed that she is suffering from an acute attack of migraine. You have decided to administer triptan considering her symptoms and risk to the fetus. Which triptan is considered safe during pregnancy?", "options": [{"label": "A", "text": "Sumatriptan", "correct": true}, {"label": "B", "text": "Zolmitriptan", "correct": false}, {"label": "C", "text": "Rizatriptan", "correct": false}, {"label": "D", "text": "Naratriptan", "correct": false}], "correct_answer": "A. Sumatriptan", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Sumatriptan The triptans are pregnancy category C drugs (i.e., there are no adequate and well-controlled studies in pregnant women; use during pregnancy only if the potential benefit justifies a potential risk to the fetus) and should also be used with caution in nursing mothers</p>\n<p><strong>Highyeild:</strong></p><p>Migraine - Triptans All triptans are available PO but only a few have other routes. ‚Ä¢ Injectable (expensive) ‚Äì sumatriptan ‚Ä¢ Intranasal (nasty aftertaste) - sumatriptan, zolmitriptan, rizatriptan ‚Ä¢ Sublingual-zolmitriptan, rizatriptan Of the PO frovatriptan and naratriptan are slower to act - this may be good in the patient that has a slow growing headache and patients who get a rebound headache after using the more rapid acting triptans. Eletriptan and almotriptan are the other triptans</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B. Zolmitriptan is an acute treatment of migraines with or without aura in adults. Zolmitriptan is not intended for the prophylactic therapy of migraine or use in the management of hemiplegic or basilar migraine. Zolmitriptan is available as a swallowable tablet, an orally disintegrating tablet, and a nasal spray. Option: C. Rizatriptan is used to treat acute migraine attacks with or without aura . It does not prevent future migraine attacks. the review found rizatriptan to be more efficacious and tolerable than sumatriptan. Rizatriptan and other triptans can cause vasoconstriction, they are contraindicated in people with cardiovascular conditions. Option: D. Naratriptan , belongs to the group of medicines called triptans. Many people find that their headaches go away completely after they take naratriptan. Other people find that their headaches are much less painful and that they are able to go back to their normal activities even though their headaches are not completely gone.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error("Questions data is empty or invalid");
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error("Failed to parse questions_json:", e);
            document.getElementById(